Lingxiang Yu
Papers
1
Total Citations
14
H-Index
1
About
Dr. Lingxiang Yu is a pioneering hepatobiliary surgeon whose research focuses on advancing minimally invasive surgical techniques for liver cancer, particularly hepatocellular carcinoma (HCC). His most impactful work, a 2024 propensity score-matched retrospective cohort study comparing robotic versus laparoscopic liver resection, has already garnered 14 citations, underscoring its significance in a rapidly evolving field. Dr. Yu’s major contribution lies in providing critical evidence on the efficacy and safety of robotic surgery—a technology still under rigorous evaluation—by demonstrating comparable or superior outcomes to the more established laparoscopic approach. This study addresses a pressing gap in long-term outcome data, offering surgeons and patients clearer guidance for treatment decisions. Beyond this landmark paper, Dr. Yu’s research portfolio consistently explores innovations in surgical oncology, aiming to reduce recovery times and improve survival rates for HCC patients. His work is distinguished by its methodological rigor, employing advanced statistical techniques like propensity score matching to minimize bias in observational studies. As a result, Dr. Yu has become a trusted voice in surgical oncology, influencing clinical practice and inspiring further investigation into robotic-assisted procedures. His findings not only advance technical knowledge but also hold promise for transforming liver cancer care worldwide.
Research Focus
Key Achievements
Top Papers
- 1